Email Us Here

Bioprognos Presents a Revolutionary Non-invasive Test for the Diagnosis of Breast Cancer

It is expected that the new test will save up to 90% of unnecessary breast biopsies that are usually done to confirm malignancy in suspicious findings in diagnostic imaging procedures (such as all classified as BI-RADS 3 and BI-RADS 4).